CARCINOEMBRYONIC ANTIGEN

MediAngels Logo  
 
Test Name
Carcinoembryonic Antigen
Test Units
ng/ml
Normal Range
  • Non - Smokers
  • <= 3.4
     
  • Smokers
  • < 4.3
    Sample required
    2 ml serum
     
    INTRODUCTION
     

    Carcinoembryonic antigen (CEA) is a glycoprotein involved in cell adhesion. It is normally produced during fetal development, but the production of CEA stops before birth. Therefore, it is not usually present in the blood of healthy adults, although levels are raised in heavy smokers. Carcinoembryonic antigen (CEA) is one of the most frequently used serum tumor markers for carcinoma, particularly in colorectal cancer. It is useful in the diagnosis and monitoring of cancer, however, specificity for CEA assays is not absolute. Therefore, it is often used in conjunction with tests for other markers.

    Since cancer prevalence in a healthy population is low, an elevated CEA has an unacceptably low positive predictive value, with excess false positives. Also, since elevated CEA occurs in the advanced stage of incurable cancer but is low in the early, curable disease, the likelihood of a positive result affecting a patient's survival is diminished. CEA has been suggested in having prognostic value for patients with colon cancer.

    Although not satisfactory for screening a healthy population, CEA has been used to monitor recurrence. Determinations of CEA should be done frequently at a minimum of every 3 months. Elevations above baseline should be verified rapidly to exclude laboratory error.

    The CEA is of some use as a monitor in treatment. Usually the CEA returns to normal within 1 to 2 months of surgery, but if elevated levels are persistant, disease may be indicated. The test is not infallible in patients treated with radiotherapy and chemotherapy but can be useful in those whose tumor is not measurable.

     
     
    CLINICAL SIGNIFICANCE
     
    Elevated levels of CEA are found in following conditions :
     
    • Colon cancer
    • Breast cancer
    • Lung cancer
    • Pancreatic cancer
    • Thyroid cancer
    • Genitourinary carcinomas
    • Inflammatory gastrointestinal diseases (for example, ulcerative colitis, diverticulitis, cholecystitis, pancreatitis)
    • Cirrhosis and other liver disease
    • Peptic ulcer
    • Heavy smoking
    • Pulmonary infections
     

    T echnology Used CLIA

      ADDITIONAL INFORMATION  
     
     

    There is a potential for false positive as well as false negative results, hence test should be frequently repeated to know the exact status of the disease.

     
     
    Copyright 2012 Angels Health Pvt Ltd. All Rights Reserved.